Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 Notice on Change of CEO 2021/03/26 HANALL BIOPHARMA CO.,LTD
9 Outcome of Annual Shareholders' Meeting 2021/03/26 HANALL BIOPHARMA CO.,LTD
8 Reporting reasons for holding general shareholders' meeting on the most concentrated date 2021/03/11 HANALL BIOPHARMA CO.,LTD
7 Decision on Calling Shareholders' Meeting 2021/03/10 HANALL BIOPHARMA CO.,LTD
6 Submission of Audit Report 2021/03/05 HANALL BIOPHARMA CO.,LTD
5 Decision on Disposal Treasury Stocks 2021/02/08 HANALL BIOPHARMA CO.,LTD
4 Decision on Disposal Treasury Stocks 2021/01/29 HANALL BIOPHARMA CO.,LTD
3 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2021/01/19 HANALL BIOPHARMA CO.,LTD
2 Interim Report on Business Performance(Fair Disclosure) 2021/01/19 HANALL BIOPHARMA CO.,LTD
1 [Revised]Organization of Investor Relations Event 2020/12/21 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
3 2019 Statement of financial position 2020-03-20
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31